Key references
McLachlan G, Davidson H, Holder E, et al. Pre-clinical evaluation of three non-viral gene transfer agents for cystic fibrosis after aerosol delivery to the ovine lung. Gene Therapy 18 (10) 996-1005 2011.
Yahaya, B., Baker, A., Tennant, P., Smith, S. H., Shaw, D. J., McLachlan, G., Collie, D. D. 2011 Analysis of airway epithelial regeneration and repair following endobronchial brush biopsy in sheep. Experimental Lung Research E-pub 8 Sept.
Griesenbach, U., Vicente, C. C., Roberts, M. J., Meng, C., Soussi, S., Xenariou, S.,
Tennant, P., Baker, A., Baker, E., Gordon, C., Vrettou, C., McCormick, D., Coles, R.,
Green, A. M., Lawton, A. E., Sumner-Jones, S. G., Cheng, S. H., Scheule, R. K.,
Hyde, S. C., Gill, D. R., Collie, D. D., McLachlan, G., Alton, E. W. 2011. Secreted Gaussia luciferase as a sensitive reporter gene for in vivo and ex vivo studies of airway gene transfer. Biomaterials 32(10): 2614-2624.
Griesenbach, U., McLachlan, G., Owaki, T., Somerton, L., Shu, T., Baker, A., Tennant, P., Gordon, C., Vrettou, C., Baker, E., Collie, D. D. S., Hasegawa, M., Alton, E. W. F. W. 2011. Validation of recombinant Sendai virus in a non-natural host model. Gene Therapy 18(2): 182-188.
McCormick, D., Sumner-Jones, S. G., Pringle, I. A., Vrettou, C., McLachlan, G., Collie, D. D., Gill, D. R., Hyde, S. C. 2010. 3-step Taqman RT-PCR: Ultimate messenger RNA detection sensitivity for CF gene therapy trials. Pediatric Pulmonology(Supplement 32): 307.
Scott, P.,Collie, D., McGorum, B., Sargison, N. 2010. Relationship between thoracic auscultation and lung pathology detected by ultrasonography in sheep. Veterinary Journal 186(1): 53-57.
Sumner-Jones, S., McCormick, D., Coles, R., Pringle, I. A., McLachlan, G., Collie, D. D.,
Vrettou, C., Davies, J. C., Alton, E. W., Gill, D. R., Hyde, S. C. 2010. Optimisation of molecular assays for clinical trila of CG67A/PNDA delivery to nose and lung of CF patients. Pediatric Pulmonology(Suppt. 32): 306.
Davidson, H., Wilson, A., Gray, R. D., Horsley, A., Pringle, I. A., McLachlan, G., Nairn, A. C., Stearns, C., Gibson, J., Holder, E., Jones, L., Doherty, A., Coles, R., Sumner-Jones, S. G., Wasowicz, M., Manvell, M., Griesenbach, U., Hyde, S. C., Gill, D. R., Davies, J.,
Collie, D. D. S., Alton, E. W. F. W., Porteous, D. J., Boyd, A. C. 2009. An immunocytochemical assay to detect human CFTR expression following gene transfer. Molecular and Cellular Probes 23(6): 272-280.
Griesenbach, U., Roberts, M. J., Vicente, C. C., Cheng, S., Scheule, R., Pringle, I. A.,
Green, A. M., Lawton, A. E., Plant, K. E., Hyde, S. C., Gill, D. R., Vrettou, C., Baker, A., Tennant, P., McLachlan, G., Collie, D. D. S., Alton, E. W. F. W. 2009. Secreted Gaussia Luciferase is a more sensitive reporter than Firefly Luciferase for non-viral gene transfer to airway epithelium ex vivo and in vivo. Molecular Therapy 17(Supplement 1): S123-S124.
Pringle, I. A., Hewitt, A. M., Connolly, M., Lawton, A. E., Voase, N. W. G., Larsen, M.,
Manvelle, M., Donovan, J., Mohamedhossen, M. H., Davies, J., Alton, E. W. F. W.,
McLachlan, G., Collie, D. D., Hyde, S. C., Gill, D. R. 2009. Exploiting single-cell-PCR technology to determine the percentage of transfected cells in the respiratory epithelium. Molecular Therapy 17(Suppt. 1): S125.
Vrettou, C., Baker, E. Tennant, P., Baker, A., Gordon, C., Sumner-Jones, S. G., Davies, J. C., Gill, D. R., McLachlan, G., Collie, D. 2009. Optimising harvest of bronchial brush biopsy samples to maximise cell and RNA yield in gene therapy studies. Molecular Therapy 17(Suppt. 1): S125.
Griesenbach, U., Vicente, C. C. Green, A. M., Cheng, S. H., Pringle, I. A., Hyde, S. C.,
Gill, D. R., McLachlan, G., Collie, D., Alton, E. W. 2008. Secreted gaussia luciferase is a sensitive reporter of gene transfer in the sheep lung. Human Gene Therapy 19(10): 1123-1123.
Krasnianski, A., Kallenberg, K., Collie, D. A., Meissner, B., Schulz-Schaeffer, W. J.,
Heinemann, U., Varges, D., Summers, D. M., Kretzschmar, H. A., Talbot, T., Will, R. G.,
Zerr, I. 2008. MRI in the classical MM1 and the atypical MV2 subtypes of sporadic CJD: an inter-observer agreement study. European Journal of Neurology 15(8): 762-771.
McNeilly, T. N., Baker, A., Brown, J. K., Collie, D., Maclachlan, G., Rhind, S. M., Harkiss, G. D. 2008. Role of alveolar macrophages in respiratory transmission of visna/maedi virus. J.Virol. 82 (3):1526-1536.
Davies, L. A., McLachlan, G., Sumner-Jones, S. G., Ferguson, D., Baker, A., Tennant, P., Gordon, C., Vrettou, C., Baker, E., Zhu, J., Alton, E. W., Collie, D. D., Porteous, D. J. Hyde, S. C. Gill., D. R. 2008. Enhanced lung gene expression after aerosol delivery of concentrated pDNA/PEI complexes. Mol.Ther. 16 (7):1283-1290
McLachlan G., A. Baker, P. Tennant et al. 2007 Optimising aerosol gene delivery and expression in the ovine lung. Mol. Ther.15 (2) 348-354.
Pringle, I.A., McLachlan, G., Collie, D.D.S et al. 2007 Electroporation enhances reporter gene expression following delivery of naked plasmid DNA to the lung. J. Gene Med. 9 (5) 369-380.
H. Davidson, G. McLachlan, A. Wilson, et al. 2006 Human-specific cystic fibrosis transmembrane conductance regulator antibodies detect in vivo gene transfer to ovine airways. Am.J.Respir.Cell Mol.Biol. 35 (1):72-83.
M. Emerson, L. Renwick, S. Tate, et al. 2003 Transfection efficiency and toxicity following delivery of naked plasmid DNA and cationic lipid-DNA complexes to ovine lung segments. Mol.Ther. 8 (4):646-653.
McLachlan, G., Stevenson, B.J. & Porteous, D.J. 2000 Bacterial DNA is implicated in the inflammatory response to delivery of DNA/DOTAP to mouse lungs. Gene Ther., 7, 384-392.
Porteous, D.J., Dorin, J.R., McLachlan, G. et al. 1997 Evidence for the safety and efficacy of DOTAP cationic liposome mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis. Gene Ther., 4(3), 210-218.
McLachlan, G., Ho, L.-H., Davidson-Smith, H. et al. 1996 Laboratory and clinical studies in support of cystic fibrosis gene therapy using pCMV-CFTR/DOTAP. Gene Ther., 3, 1113-1123.
McLachlan, G., Davidson, D.J., Stevenson, B.J. et al. 1995 Evaluation in vitro and in vivo of cationic liposome-expression construct complexes for cystic fibrosis gene therapy. Gene Ther., 2, 614-622.